Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Berrin Balik Aydin"'
Autor:
Berrin Balik Aydin
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S31- (2023)
Objective: Neurotoxicity is a well-recognized complication of high-dose cytosine arabinoside (HIDAC). We describe a patient with AML who suffered cerebellar toxicity following high-dose cytarabine and showed excellent response to methylprednisolone.
Externí odkaz:
https://doaj.org/article/9919ed01355a4b9f9b2485cd2c162da7
Publikováno v:
HemaSphere, Vol 6, Iss 7, p e728 (2022)
Externí odkaz:
https://doaj.org/article/a2196e18ef2c45a4aa0c271b0ca45919
Autor:
Yaşa Gül Mutlu, Berrin Balik Aydin, Cem Erdogan, Deniz Kizilaslan, Hüseyin Saffet Beköz, Aliihsan Gemici, Leylagül Kaynar, Ömür Gökmen Sevindik
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 39:167-172
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 2, Pp 173-174 (2021)
Turkish Journal of Hematology
Turkish Journal of Hematology
A 46-year-old female was admitted to our clinic suffering from long-standing leukocytosis. She was evaluated at another hospital regarding this lymphocytic leukocytosis (absolute lymphocyte count: 10770/µL) with no final diagnosis despite further wo
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S286
Objective: The management of R/R-HCL is not standardized yet. Patients with HCL universally harbor BRAF mutations, which makes BRAF inhibitors a potential treatment approach. The efficacy and safety of the BRAF inhibitor Vemurafenib were evaluated bo
Autor:
Yaşa Gül Mutlu, Berrin Balık Aydın, Aslı Çakır, Özlem Canöz, Cengiz Erol, Ömür Gökmen Sevindik
Publikováno v:
Eurasian Journal of Medicine, Vol 55, Iss 2, Pp 114-119 (2023)
Externí odkaz:
https://doaj.org/article/b4f40e0abad349d99aa703eb7f421661
Autor:
Mehmet Sinan, Dal, Abdullah, Karakus, Tuba, Dal, Berrin Balik, Aydin, Elif, Hattapoglu, Mehmet Onder, Ekmen, Turgay, Ulas, Orhan, Ayyildiz
Publikováno v:
JPMA. The Journal of the Pakistan Medical Association. 67(7)
Immune thrombocytopenia (ITP) is an immune haematologic disorder causing platelet destruction mediated by anti-platelet antibodies. In this study we aimed to evaluate the clinical and laboratory variables of ITP patients in southeast of Turkey.In thi
Autor:
Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden, Fehmi Hindilerden, Neslihan Andıç, Mustafa Baydar, Lale Aydın Kaynar, Selami Koçak Toprak, Hasan Sami Göksoy, Berrin Balık Aydın, Ufuk Demirci, Ferda Can, Vildan Özkocaman, Eren Gündüz, Zeynep Tuğba Güven, Zübeyde Nur Özkurt, Sinan Demircioğlu, Meral Beksaç, İdris İnce, Umut Yılmaz, Hilal Eroğlu Küçükdiler, Elgün Abishov, Boran Yavuz, Ünal Ataş, Yaşa Gül Mutlu, Volkan Baş, Fahir Özkalemkaş, Hava Üsküdar Teke, Vildan Gürsoy, Serhat Çelik, Rafiye Çiftçiler, Münci Yağcı, Pervin Topçuoğlu, Özcan Çeneli, Hamza Abbasov, Cem Selim, Muhlis Cem Ar, Orhan Kemal Yücel, Sevil Sadri, Canan Albayrak, Ahmet Muzaffer Demir, Nil Güler, Muzaffer Keklik, Hatice Terzi, Ali Doğan, Zeynep Arzu Yegin, Meltem Kurt Yüksel, Soğol Sadri, İrfan Yavaşoğlu, Hüseyin Saffet Beköz, Tekin Aksu, Senem Maral, Veysel Erol, Leylagül Kaynar, Osman İlhan, Ali Zahit Bolaman, Ömür Gökmen Sevindik, Arzu Akyay, Muhit Özcan, Günhan Gürman, Şule Ünal, Yasemin Yavuz, Reyhan Diz Küçükkaya, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 1, Pp 43-54 (2022)
Objective: Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly immunosuppressed populations, such as
Externí odkaz:
https://doaj.org/article/ef03a300a9a44beba39b3be598d50f71
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 2, Pp 173-174 (2021)
Externí odkaz:
https://doaj.org/article/edb5fc7417714784abf82a80206259c4